BRAIN Biotech AG resolves on a cash capital increase from authorised capital

15 September 2021, Zwingenberg (Germany) - The Management Board of BRAIN Biotech AG today has resolved to increase the company’s share capital against cash contribution. The company’s share capital shall be increased against cash contribution by issuing new registered shares with no par value. Each such share has a notional value of EUR 1.00 of the Company’s share capital (the “New Shares”).